Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Does the market know something???
View:
Post by Looking4Doubles on Jun 17, 2020 1:02pm

Does the market know something???

Both markets just jumped in a meaningful way.  U.S. up 60%, Canada up 20%
Comment by Moonshiner592 on Jun 17, 2020 1:36pm
... I believe they do!
Comment by wood56 on Jun 17, 2020 3:57pm
A whole $38,000, I don't think they do
Comment by Moonshiner592 on Jun 17, 2020 4:08pm
  ... still higher than the usual ... news coming soon 
Comment by Raiders11 on Jun 17, 2020 4:09pm
17 MILLION shares on the ask up to 5 cents,Rob needs to pull a quite a few rabbits out of his sphincter to get this gaining any share price increase!
Comment by Newinvestor68 on Jun 17, 2020 6:01pm
Rob doesn't care about stock price. He gets his $378k per year for regurgitating the same press realeases. He owns a measly 1.9 million shares which is worth $57k. It is better for him to drag this own so he keeps collecting his salary. Can we vote him off the island? I will take his job for $100k and will do the 2 hours of work per year that he puts into this.  lastly way doesn't ...more  
Comment by Jack4000 on Jun 17, 2020 6:45pm
This post has been removed in accordance with Community Policy
Comment by Newinvestor68 on Jun 17, 2020 8:14pm
Source about him carrying about stock price? No source but tell me what good has happened with this company? Nothing, the way they keep diluting the shares leads me to believe that. I absolutely don't know that much about the ins and outs of running a public company but based on the success of Kalytera Rob knows how to pretty up press releases and move things around but not how to run a ...more  
Comment by Moonshiner592 on Jun 17, 2020 8:29pm
.... arrogant reply?? ... no arrogance there from what I read .. ... further - Kly is very close to a very pivotal point with its highly potential involvement with COVID .. Patience is key - let's see how the NR's look in about the next 6 weeks ..  GLTA
Comment by Jack4000 on Jun 17, 2020 8:39pm
This post has been removed in accordance with Community Policy
Comment by Jack4000 on Jun 17, 2020 8:40pm
This post has been removed in accordance with Community Policy
Comment by Jack4000 on Jun 17, 2020 8:43pm
This post has been removed in accordance with Community Policy
Comment by Jack4000 on Jun 17, 2020 9:30pm
This post has been removed in accordance with Community Policy
Comment by Moonshiner592 on Jun 17, 2020 9:56pm
Agreed - thanks Jack     
Comment by Sorrento on Jun 18, 2020 10:50pm
I hear the fat lady singing....
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities